<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7410516\results\search\testTrace\results.xml">
  <result pre="in paediatric patients as well, and in some cases, the" exact="infection" post="presented neurological sequelae. Furthermore, children with particular neurological diseases"/>
  <result pre="symptoms. Further, psychiatric population may be more vulnerable to the" exact="infection" post="and at higher risk for adverse outcomes. Keywords COVID-19"/>
  <result pre="showed a close similarity with the virus responsible for SARS" exact="infection" post="in 2003; hence, it was named SARS-CoV-2 [2]. One"/>
  <result pre="COVID-19. Due to the rapid and extensive spreading of the" exact="infection" post="from China to Europe and worldwide, the WHO declared"/>
  <result pre="immediate clinical questions can be difficult and time-consuming particularly regarding" exact="treatment" post="strategies [7, 8]. We herein reviewed the best evidence"/>
  <result pre="physical difficulties, but also because of the challenging issue of" exact="treatment" post="needs alongside drugâ€™s long-term effects. These factors together with"/>
  <result pre="by SARS-CoV-2 Human coronaviruses (HCoVs) commonly share viral structures and" exact="infection" post="mechanisms, together with the potential for host central nervous"/>
  <result pre="adhesion is guaranteed, an additional axonal transport leads to early" exact="infection" post="spread to the piriform cortex and other regions associated"/>
  <result pre="long-term neurological sequelae [15, 17, 18, 24]. Moreover, the direct" exact="infection" post="of cardiorespiratory centres in the CNS seems strong to"/>
  <result pre="manifestations. Hence, COVID-19 has to be suspected in the differential" exact="diagnosis" post="of patients with neurological symptoms, especially in highly epidemic"/>
  <result pre="to 5.6 and 5.1% of patients, respectively) [22]. Hitherto, the" exact="prevalence" post="of COVID-19-related olfactory and taste disorders (OTDs) has been"/>
  <result pre="of SARS-CoV-2 that may help for the timely suspicion and" exact="isolation" post="of COVID-19 patients. One of the first cases of"/>
  <result pre="several authors reported cases of Guillain-BarrÃ© syndrome associated with SARS-CoV-2" exact="infection" post="[39â€&quot;42]. The main etiopathological hypothesis involves â€œmolecular mimicryâ€�, by"/>
  <result pre="Impact of COVID-19 in patients with chronic neurological diseases SARS-CoV-2" exact="infection" post="has impacted on the health and well-being of patients"/>
  <result pre="forms of COVID-19, they recommended that clinicians should consider interrupting" exact="treatment" post="in case of comorbidities or worsening of symptoms. However,"/>
  <result pre="for different diseases [52â€&quot;54]. Neurological complications of COVID-19-related treatments As" exact="treatment" post="for COVID-19 constantly evolves, following the newest evidence of"/>
  <result pre="inhibition [65]. Lopinavir and ritonavir have been employed in COVID-19" exact="treatment" post="[66], although contradictory results have been observed and their"/>
  <result pre="involvement in children COVID-19 seems to have a relatively low" exact="prevalence" post="in children, which represent from 1.7 [71] to 2.4%"/>
  <result pre="In Italy, 1.9% of reported cases were 73]. Nonetheless, SARS-CoV-2" exact="infection" post="shows different characteristics in children compared with the adult"/>
  <result pre="disease seem to occur mainly in younger children, with a" exact="prevalence" post="of 10.6% and 7.3% for the age groups of"/>
  <result pre="psychiatric disorders It is difficult to discern whether the high" exact="prevalence" post="of psychiatric disorders diagnosed during the past SARS-CoV-1 epidemic"/>
  <result pre="past SARS-CoV-1 epidemic and largely found in patients with SARS-CoV-2" exact="infection" post="are a direct consequence of the central nervous system"/>
  <result pre="disruption of personal and social healthcare and lifestyle [80]. SARS-CoV-2" exact="infection" post="has recently been implicated in the onset of psychosis,"/>
  <result pre="comorbid physical health problems and smoking habits [7]. Furthermore, psychiatric" exact="treatment" post="in COVID-19 patients is a source of medical concern."/>
  <result pre="and insomnia, which can be difficult to discern from antiviral" exact="treatment" post="side effects. In this regard, many patients will need"/>
  <result pre="interventions, no drugs can be recommended for the prevention or" exact="treatment" post="of ICU delirium other than avoidance of overuse of"/>
  <result pre="The coronavirus disease of 2019 (COVID-19) that is caused by" exact="infection" post="with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"/>
  <result pre="to direct pulmonary injury. Necessary adaptations in management, triage and" exact="diagnosis" post="are needed, especially for subjects suffering from chronic and"/>
  <result pre="pediatric neurologistâ€™s perspective. Indian J Pediatr 87(7):556â€&quot;557. 10.1007/s12098-020-03326-8 10.LuXZhangLDuHZhangJLiYYQuJet al.SARS-CoV-2" exact="infection" post="in childrenN Engl J Med2020382171663166532187458 11.Li YC, Bai WZ,"/>
  <result pre="OC43. J Virol 92(17):e00404-18. 10.1128/JVI.00404-18 15.NetlandJMeyerholzDKMooreSCassellMPerlmanSSevere acute respiratory syndrome coronavirus" exact="infection" post="causes neuronal death in the absence of encephalitis in"/>
  <result pre="Virol200882157264727518495771 16.AndriesKPensaertMBImmunofluorescence studies on the pathogenesis of hemagglutinating encephalomyelitis virus" exact="infection" post="in pigs after oronasal inoculationAm J Vet Res1980419137213786255837 17.BaigAMKhaleeqAAliUSyedaHEvidence"/>
  <result pre="X, Chen Z, et al (2020) Nervous system involvement after" exact="infection" post="with COVID-19 and other coronaviruses. Brain Behav Immun 87:18â€&quot;22."/>
  <result pre="review on the efficacy and safety of chloroquine for the" exact="treatment" post="of COVID-19J Crit Care20205727928332173110 57.Gautret P, Lagier JC, Parola"/>
  <result pre="Parola P, et al (2020) Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trial."/>
  <result pre="Advances in the use of chloroquine and hydroxychloroquine for the" exact="treatment" post="of COVID-19. Postgrad Med:1â€&quot;10. 10.1080/00325481.2020.1778982 59.ChenJLiuDLiuLLiuPXuQXiaLLingYHuangDSongSZhangDQianZLiTShenYLuHA pilot study of"/>
  <result pre="COVID-19. Postgrad Med:1â€&quot;10. 10.1080/00325481.2020.1778982 59.ChenJLiuDLiuLLiuPXuQXiaLLingYHuangDSongSZhangDQianZLiTShenYLuHA pilot study of hydroxychloroquine in" exact="treatment" post="of patients with moderate COVID-19Zhejiang Da Xue Xue Bao"/>
  <result pre="relevant drug-drug interaction between AEDs and medications used in the" exact="treatment" post="of COVID-19 patients. Italian League Against Epilepsy 66.Jean SS,"/>
  <result pre="epidemiological features. Clin Infect Dis. 10.1093/cid/ciaa198 75.XuYLiXZhuBLiangHFangCGongYGuoQSunXZhaoDShenJZhangHLiuHXiaHTangJZhangKGongSCharacteristics of pediatric SARS-CoV-2" exact="infection" post="and potential evidence for persistent fecal viral sheddingNat Med202026450250532284613"/>
 </snippets>
</snippetsTree>
